Ascend Wellness Holdings, Inc.
AAWH· OTC
Released Aug 2, 2024, after the close
10-Q filed Aug 7, 2024, 38 days after period end · 0001628280-24-035669
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $141.54M | $122.99M | $97.50M | $83.37M |
| Net Income | -$21.78M | $841.00K | -$21.17M | -$44.90M |
| EPS Diluted |
Ascend Wellness Holdings, Inc. · CIK 1756390 · Engraved from SEC EDGAR
| -$0.10 |
| $0.00 |
| -$0.11 |
| -$0.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.